D.M. Burger

570 total citations
27 papers, 461 citations indexed

About

D.M. Burger is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, D.M. Burger has authored 27 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 11 papers in Virology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in D.M. Burger's work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). D.M. Burger is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). D.M. Burger collaborates with scholars based in Netherlands, Thailand and United Kingdom. D.M. Burger's co-authors include P.P. Koopmans, Y. A. Hekster, E.W. Wuis, David Back, Courtney V. Fletcher, C. J. L. la Porte, Terrence F. Blaschke, Charles Flexner, J G Gerber and Angela D. M. Kashuba and has published in prestigious journals such as Clinical Infectious Diseases, Clinical Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

D.M. Burger

26 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.M. Burger Netherlands	12	364	193	106	93	70	27	461
Monique M. R. de Maat Netherlands	10	431 1.2×	229 1.2×	121 1.1×	100 1.1×	118 1.7×	15	606
C. J. L. la Porte Canada	11	433 1.2×	201 1.0×	129 1.2×	91 1.0×	137 2.0×	16	546
Steve West United States	7	339 0.9×	195 1.0×	71 0.7×	75 0.8×	56 0.8×	9	408
Aurélie Barrail‐Tran France	16	387 1.1×	194 1.0×	83 0.8×	117 1.3×	112 1.6×	35	639
Keith Erdman United States	7	327 0.9×	234 1.2×	111 1.0×	83 0.9×	40 0.6×	9	504
Catherine Gillotin France	15	278 0.8×	171 0.9×	86 0.8×	71 0.8×	90 1.3×	26	616
Neil Buss Switzerland	13	375 1.0×	252 1.3×	90 0.8×	71 0.8×	130 1.9×	17	655
Sara E. Gibbons United Kingdom	9	485 1.3×	330 1.7×	125 1.2×	113 1.2×	120 1.7×	13	594
Michael L. Lim United States	9	502 1.4×	305 1.6×	66 0.6×	155 1.7×	99 1.4×	11	574
Aurélie Fayet Switzerland	9	408 1.1×	254 1.3×	111 1.0×	61 0.7×	58 0.8×	11	552

Countries citing papers authored by D.M. Burger

Since Specialization

Citations

This map shows the geographic impact of D.M. Burger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.M. Burger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.M. Burger more than expected).

Fields of papers citing papers by D.M. Burger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.M. Burger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.M. Burger. The network helps show where D.M. Burger may publish in the future.

Co-authorship network of co-authors of D.M. Burger

This figure shows the co-authorship network connecting the top 25 collaborators of D.M. Burger. A scholar is included among the top collaborators of D.M. Burger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.M. Burger. D.M. Burger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Beunders, Remi, Oliver Hartmann, Janin Schulte, et al.. (2024). A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed. Cancer Chemotherapy and Pharmacology. 94(6). 799–806. 2 indexed citations

2.

Brake, Lindsey H. M. te, et al.. (2023). Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 238. 115832–115832. 8 indexed citations

3.

Rokx, Casper, D.M. Burger, Annelies Verbon, et al.. (2018). Predictors of virological failure in HIV‐1‐infected patients switching to dolutegravir maintenance monotherapy. HIV Medicine. 20(1). 63–68. 12 indexed citations

4.

Burger, D.M., et al.. (2017). A Call for a Consortium for Optimal Management of Drug–Drug Interactions in Patient Care. Clinical Pharmacology & Therapeutics. 102(3). 391–394. 4 indexed citations

5.

Heide, Iris van der & D.M. Burger. (2009). Etravirine biedt hoop bij aids. Nieuw hiv-middel geeft minder bijwerkingen en resistentie.. 144. 18–20. 1 indexed citations

6.

Brüggemann, Roger J. M., Nicole M. A. Blijlevens, D.M. Burger, et al.. (2009). Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients. Journal of Antimicrobial Chemotherapy. 65(1). 107–113. 33 indexed citations

7.

Avihingsanon, Anchalee, Jasper van der Lugt, Stephen J. Kerr, et al.. (2008). A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults. Clinical Pharmacology & Therapeutics. 85(4). 402–408. 29 indexed citations

8.

Oyen, Wim J.G., et al.. (2008). The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D‐deficient HIV‐1‐infected patients. HIV Medicine. 9(9). 771–779. 23 indexed citations

9.

Dickinson, Laura, Marta Boffito, David Back, et al.. (2008). Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals. Journal of Antimicrobial Chemotherapy. 62(6). 1344–1355. 11 indexed citations

10.

Koopmans, P.P., et al.. (2008). Stavudine plasma concentrations and lipoatrophy. Journal of Antimicrobial Chemotherapy. 61(4). 933–938. 10 indexed citations

11.

Wyen, Christoph, Uwe Fuhr, Dorothee Frank, et al.. (2008). Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients. Clinical Pharmacology & Therapeutics. 84(1). 75–82. 67 indexed citations

12.

Droste, J. A. H., R.E. Aarnoutse, & D.M. Burger. (2007). Determination of Emtricitabine in Human Plasma using HPLC with Fluorometric Detection. Journal of Liquid Chromatography & Related Technologies. 30(18). 2769–2778. 24 indexed citations

13.

Oosterhout, JJ van, Neena Bodasing, Moffat Nyirenda, et al.. (2006). Evaluation of antiretroviral therapy results in Blantyre, Malawi. Malawi Medical Journal. 17(4). 112–6. 1 indexed citations

14.

Fraaij, Pieter L. A., Jennifer Neubert, Alina S Bergshoeff, et al.. (2004). Safety and efficacy of a NRTI sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1 infected children.. The Pediatric Infectious Disease Journal. 9. 297–299. 1 indexed citations

15.

Bergshoeff, Alina S, et al.. (2004). Nelfinavir Plasma Concentrations Are Low during Pregnancy. Clinical Infectious Diseases. 39(5). 736–740. 31 indexed citations

16.

Rossum, Annemarie M. C. van, Alina S Bergshoeff, Pieter L. A. Fraaij, et al.. (2002). Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in HIV-1 infected children.. The Pediatric Infectious Disease Journal.

17.

Koks, Cornelis H.W., Kristel M. L. Crommentuyn, Richard M. W. Hoetelmans, et al.. (2001). The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals. British Journal of Clinical Pharmacology. 51(6). 631–635. 19 indexed citations

18.

Burger, D.M., et al.. (2000). Determination of nevirapine, an HIV-1 non nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high perfomance liquid chromatography. Journal of Chromatography B. 744. 64–71. 1 indexed citations

19.

Burger, D.M., et al.. (1997). Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B. 703. 235–241. 30 indexed citations

20.

Burger, D.M., et al.. (1997). Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 703(1-2). 235–241. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact